Atea Pharmaceuticals stock price
아테아 파머슈티컬스NASDAQ:AVIR · Nasdaq · Healthcare$5.13+0.59%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Atea Pharmaceuticals last closed at $5.13 (+0.59%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -2.5×. Its overall grade ranks 356 of 739 stocks in Healthcare.
About this company
Atea Pharmaceuticals last closed at $5.13 (+0.59%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B · 356/739
Valuation grade B+
Related stocks
- RocheCustomer
Atea의 주요 항바이러스 개발 후보 물질은 대형 제약사와의 공동개발·상업화 가능성이 핵심
- MerckCompetitor
항바이러스제 및 감염병 치료제 개발 영역에서 경쟁하는 글로벌 대형 제약사
- Gilead SciencesCompetitor
C형간염 등 항바이러스 치료제 시장의 대표 경쟁사
About Atea Pharmaceuticals
- What technical signals does Atea Pharmaceuticals (AVIR) have?
- Atea Pharmaceuticals current technical signals: no active technical signal.
- Is Atea Pharmaceuticals a cup-and-handle pattern?
- No. Atea Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Atea Pharmaceuticals?
- Market cap: $400.79M. Trailing 12 months PER: -2.5×. Latest quarter PBR: 2.01×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Atea Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy